Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00143273
Status:
COMPLETED
Last Update Posted:
2011-08-10
First Post:
2005-08-31
Brief Title:
Dose Response Study of Lasofoxifene in Postmenopausal Women With Osteoporosis - Japanese Asian Dose Evaluation
Sponsor:
Ligand Pharmaceuticals
Organization:
Ligand Pharmaceuticals
Organization Data
Organization:
Ligand Pharmaceuticals
Class:
INDUSTRY
Study ID:
A2181037
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ligand Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Director Project Management
Old Organization:
Ligand Pharmaceuticals